# Prevention of Metabolic Acidosis in Preterm Neonates by Replacing Sodium Chloride With Sodium Acetate in Parenteral Nutrition

> **NCT06545565** · PHASE3 · RECRUITING · sponsor: **Aga Khan University Hospital, Pakistan** · enrollment: 200 (estimated)

## Conditions studied

- Metabolic Acidosis
- Neonatal Disease
- Neonatal Complication

## Interventions

- **DRUG:** sodium acetate group will receive sodium acetate in the neonatal PN.
- **DRUG:** sodium chloride group will receive sodium chloride in the neonatal PN.

## Key facts

- **NCT ID:** NCT06545565
- **Lead sponsor:** Aga Khan University Hospital, Pakistan
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-10
- **Primary completion:** 2025-05-10
- **Final completion:** 2025-05-10
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06545565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06545565, "Prevention of Metabolic Acidosis in Preterm Neonates by Replacing Sodium Chloride With Sodium Acetate in Parenteral Nutrition". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06545565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
